Sandoz Fails To Obtain US Remodulin Injunction

But United Therapeutics And Smiths Cannot Dismiss Suit

 
• By Akriti Seth
  
Chess_Board_Smoke
Sandoz, Raregen, United and Smiths are now awaiting trial • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin